CDC20 and neoplasm: Bub1bN and Bub1bΔN, however, were unable to ameliorate the tumor burden of KrasLA1 mice, indicating that binding of Cdc20 mediated by the N-terminal domain is necessary, but not sufficient, to protect against tumor formation.